Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Raybow Pharmaceutical is a global Contract Development and Manufacturing Organization (CDMO) that provides comprehensive outsourcing solutions for the pharmaceutical and biotechnology industries. As the CDMO division of Jiuzhou Pharmaceutical, the company specializes in the development and manufacturing of small molecule drug substances, ranging from preclinical stages to commercial supply. Raybow operates a sophisticated network of R&D and manufacturing sites across China, the United States, and Europe, including a significant former Bristol Myers Squibb facility in Ireland. Their technical capabilities include advanced process chemistry, continuous flow manufacturing, biocatalysis, and the production of high-potency APIs. With a strong track record of regulatory compliance and quality, Raybow serves as a strategic partner for global drug innovators seeking to accelerate their development timelines.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Raybow Pharma.